Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.44 USD | +0.07% | -0.02% | +122.94% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
- Stock Market
- Equities
- FUSN Stock
- News FUSN PHAR
- Wedbush Adjusts Price Target for Fusion Pharmaceuticals to $19 From $20, Maintains Outperform Rating